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Background: Metanephric adenoma (MA) is a benign renal tumor that is difficult to distinguish from a malignant
tumor via traditional radiography. The diagnosis of MA is often dependent on postsurgical histopathological
examination. In the present report, the imaging features of MA on computer tomography (CT) and magnetic
resonance imaging (MRI) were retrospectively evaluated.
Methods: Eight MA patients, 17–67 years of age, were pathologically confirmed and recruited between April 2009
and November 2014. Four of the eight patients were female. All patients underwent CT scanning, and one patient
underwent MRI scanning. Three patients underwent CTA of the renal arteries. All patients underwent resection
surgery (radical nephrectomy in five and nephron-sparing surgery in three patients).
Results: The average tumor size was 44.0 ± 23.6 mm. The lesions in 87.5 % cases were located both in the renal
cortex and medulla and exhibited exophytic growth. Plain CT showed that MA tumors were solid, and the average
CT value was 37.9 ± 6.7 HU. Dynamic contrast-enhanced CT revealed that enhanced degrees of
MA tumors in the renal cortex, renal parenchymal, and pelvic phase were all lower than that of normal renal
parenchyma. A slight enhancement in the renal cortex phase and an even higher enhancement in the renal
parenchymal phase were observed in seven of the cases. Progressive enhancement in the pelvic phase was found
in five cases and a slight decreased enhancement in the pelvic phase in two cases. MRI revealed that MA tumor
was isointense on T1WI and isointense on T2WI with some slightly hyperintense areas in the center. CTA of the
renal arteries revealed the nutrient artery in one patient and no nutrient artery in two. Immunohistochemical
experiments demonstrated that most tumor cells were positive for vimentin, CK, and EMA.
Conclusions: MA is a rare benign renal neoplasm. Detailed knowledge of the CT and MRI characteristics of MA
plays an important role in MA diagnosis and treatment.
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Metanephric adenoma (MA) is described as a rare
benign renal tumor presented at any age, especially in
middle-aged people. It accounts for 0.2 % of adult renal
epithelial tumors and is more common in females than
in males [1]. Pathologically, MA arises from the residual
renal tissue in the embryonic kidney development
process. The pathologic morphogenetic characteristics
and biological behavior of MA are unique [2]. It is easy
to distinguish MA from the renal cell carcinoma.* Correspondence: chengjl@zzu.edu.cn
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from renal cell carcinoma through clinical or radio-
logical checks [3, 4].
The clinical symptoms of MA include polycythemia,
abdominal pain, hematuria, and a palpable mass [5, 6].
However, patients with MA are commonly asymptomatic
and the lesions are incidentally found. The clinical and
anatomic characteristics are not yet well defined for this
rare type of renal tumor. There have been limited studies
focusing on CT and MRI, and this has contributed to the
low accuracy in diagnosing MA preoperatively using
imaging. This has often resulted in un-necessary total
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utility of CT and MRI in patients with MA. We retro-
spectively studied the CT and MRI features of eight
pathologically-confirmed MA patients who were admit-
ted to our center between April 2009 and November
2014.Materials and methods
Patients
Eight MA patients diagnosed with pathology were
included in this report. All patients were hospitalized
at the First Affiliated Hospital of Zhengzhou University
from April 2009 to November 2014. The detailed
clinical parameters, clinical symptoms, and imaging
features are displayed in Tables 1 and 2. This work
was approved by the Ethics Committee of the First
Affiliated Hospital of Zhengzhou University (reference
number: 2013-No.5 speedy trial of scientific research).
Written informed consent for publication of the pa-
tient’s information and images was obtained from all
patients.CT scanning
All patients underwent CT scanning using a 64-slice CT
scanner (LightSpeed VCT, GE Healthcare, USA). Plain
CT and dynamic contrast-enhanced CT were performed.
The scanning parameters were as follows: tube voltage,
120 kV; tube current, 250 mAs; detector collimation,
64 × 0.625 mm; gantry rotation time, 0.8 s/r; pitch,
0.984; and field-of-view, 250. The slice thickness was
5 mm in the plain scanning of bilateral kidneys. For
contrast-enhanced CT scanning, 80–100 ml of omnipa-
que at a concentration of 350 mg/mL was injected into
the antecubital vein. The injection dose was 1.4–1.6 ml/
kg at a speed of 3.5 ml/s. Then, 30, 90, and 300 s after
the injection of a contrast-enhancing agent, the patients
went through the cortex phase, parenchymal phase, and
pelvic phase. Three patients underwent CT angiography
(CTA) of the renal arteries.Table 1 The characteristics of subjects
Number Gender Age (years) Symptoms
1 Female 28 Asthenia, asarcia, inappetence
2 Male 17 flank pain
3 Male 43 No
4 Female 28 No
5 Female 67 No
6 Female 57 No
7 Male 47 gross hematuria
8 Male 60 flank pain
RN radical nephrectomy, NSS nephron-sparing surgeryMRI scanning
One patient underwent MRI scanning using a 3.0 T MR
Scanner (MAGNETOM Verio, Siemens AG, Germany)
with an eight-channel phased-array body coil. The
following sequences were available for all the MR exam-
inations: axial GRE T1-weighted in-phase/out-of-phase
images (TR, 130 ms; TE, 4.8 ms and 2.5 ms respect-
ively); axial FSE T2-weighted images with fat saturation
(TR, 3000 ms; TE, 90 ms); flip angle, 70°; field of
view, 40 × 40 cm; and matrix, 320 × 189. The patients
performed a breath-hold in all the sequence scans men-
tioned above.
Pathologic examination
All patients underwent tumor resection, five underwent
radical nephrectomy, and three underwent nephron-
sparing surgery. The shape and size of tumors were
assessed via visual inspection. Cystic components and me-
tastasis were evaluated during surgery. The tumor speci-
mens were fixed with 10 % formaldehyde. Conventional
paraffin sections were conducted subsequently. The
histological and pathological results were assessed with
hematein-eosin staining and immunohistochemical
staining, respectively.
Statistical analysis
All the data were analyzed using Microsoft Excel. The
measurement data were shown as mean ± standard devi-
ation (SD).
Results
Subjects’ characteristics and preoperative diagnosis
Eight patients were included in this report. The average
age of patients was 43.4 ± 17.7 years (ranging from 17 to
67), with four females and four males. For the pre-
operative diagnosis, six cases were misdiagnosed as renal
cell carcinoma, and two were misdiagnosed as renal
hamartoma. Half of the patients had clinical symptoms
(gross hematuria, n = 1; asthenia, asarcia, and inappe-
tence, n = 1; flank pain, n = 2). The other four patients’Treatment Metastasis Side Tumor size (mm) Shape
RN No Left 38 Oval
RN No Right 94 irregular
NSS No Right 40 Round
NSS No Right 29 Round
RN No Right 25 Round
RN No Right 35 Round
RN No Right 24 Round
NSS No Right 35 Round

















1 No No Homogeneous 44 62 101 99 ND ND
2 multi
patchy
Multiple Heterogeneous 44 109 153 89 Nutrient
artery
ND
3 No Yes Slightly
heterogeneous
44 52 57 51 No nutrient
artery
ND
4 No No Homogeneous 41 51 58 70 ND ND
5 No No Homogeneous 37 54 62 66 No nutrient
artery
ND
6 No Yes Heterogeneous 25 45 65 78 ND ND
7 No No Homogeneous 34 57 63 67 ND ND
8 No No Homogeneous 34 54 60 71 ND isointense on T1WI, isointense
on T2WI with some slightly
hyperintense areas in the center
ND not done
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examination.
Characteristics of the tumors
As noted previously, all patients underwent tumor resec-
tion, five underwent radical nephrectomy, and three
underwent nephron-sparing surgery. The average size of
the tumors was 44.0 ± 23.6 mm (range from 24 to
94 mm). Only one was on the left side, and the other
seven were on the right. Seven of the tumors were round
or oval, and one was irregular in shape. Lesions were lo-
cated both in the renal cortex and medulla in seven and
projected outside of the renal contour. The tumor exhib-
ited exophytic growth. However, the lesion was located
in the medulla nephrica in only one patient.
CT findings
Plain CT showed that all the tumors were solid. The
average CT value was 37.9 ± 6.7 HU. Seven of the tu-
mors appeared as isodense (equal to the normal renal
parenchyma, Figs. 1 and 2), and one as hypodense (lower
than the normal renal parenchyma). The lesions were
homogeneous in density in five patients (Fig. 1). Hetero-
geneous tumors were accompanied with few cystic
changes or necrosis in two patients (Fig. 2) and with
multiple patchy calcifications and cystic changes or
necrosis in one case. Plain CT showed that the lesions
were hardly distinguished from the normal renal paren-
chyma in all patients.
Dynamic contrast-enhanced CT revealed that en-
hanced degrees of the tumors in the renal cortex phase,
renal parenchymal phase, and pelvic phase were all
lower than that of the normal renal parenchyma (Figs. 1,
2, and 3). A slight enhancement in the renal cortexphase (Figs. 1b and 2b) and further enhancement in the
renal parenchymal phase (Figs. 1c and 2c) were ob-
served in seven patients. Progressive enhancement in
the pelvic phase (Fig. 1d) was observed in five pa-
tients and a slight decreased enhancement in the pel-
vic phase in two (Fig. 2d). One patient had a phyma
with irregular mixed density, and the enhanced CT
showed a heterogeneous enhancement (Fig. 3a). Solid
parts were obvious enhancements in the renal cor-
tical phase, continuous enhancements in the paren-
chymal phase, and obvious decreased enhancements
in the pelvic phase. In different phases of the en-
hanced CT, the lesions were distinguished from the
normal renal parenchyma. Three patients underwent
CTA of the renal arteries; the images revealed the
nutrient artery in one patient (Fig. 3b) and no nutri-
ent artery in two.
MRI findings
One patient underwent MRI scanning. T1WI of the
tumor showed nearly isointense to renal parenchyma
(Fig. 4a). T2 weighted, fat suppressed image showed
nearly isointense to renal parenchyma with some slightly
hyperintense areas in the center (Fig. 4b).
Metastasis and hydronephrosis
In this report, no metastasis of enlarged retroperitoneal
lymph nodes, renal vessels, and the inferior vena cava was
observed in any case. No patients had hydronephrosis.
Pathological characteristics
The pathological characteristics of MA are shown in
Figs. 1e, 2e, and 3c. Solid neoplasia was observed in the
kidney and easily distinguished with adjacent tissue via
Fig. 2 A 43-year-old male with metanephric adenoma in the upper pole of the right kidney (case 3). Plain CT showed a round, poorly defined
isodense mass with a little patchy low-density areas in the renal cortex and medulla and the lesion projected outside of the renal contour. The CT
value of the mass was 44 HU (a). Dynamic contrast-enhanced CT revealed a slight enhancement of the tumors in the cortex phase with a CT value of
52 HU (b), a further enhancement in the parenchymal phase with a CT value of 57 HU (c), and a slightly decreased enhancement in the pelvic phase
with a CT value of 51 HU (d). Pathology was assessed with hematein-eosin staining and showed that the morphology of tumor cells was uniform with
tubular and acinar architecture (magnification, 40 × 10, e). The kidney outline has been marked with red line
Fig. 1 A 28-year-old female with metanephric adenoma in the mid and lower poles of the right kidney (case 4). Plain CT showed a round homogeneous
isodense mass with a poorly defined margin in the renal medulla. The CT value of the mass was 41 HU (a). Dynamic contrast-enhanced CT revealed a
progressive enhancement in the cortex phase (b), parenchymal phase (c), and pelvic phase (d). The CT values of all three phases, respectively, were 51 HU,
58 HU, and 70 HU, lower than that of the normal renal parenchyma. Pathology was assessed with hematein-eosin staining and showed that the
morphology of tumor cells was uniform with tubular and acinar architecture (magnification, 40 × 10, e)
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Fig. 3 A 17-year-old male with metanephric adenoma in the mid and upper poles of the right kidney (case 2). Dynamic contrast-enhanced CT
revealed an irregular lesion with a heterogeneous enhancement, multiple patchy calcifications, and cystic changes/necrosis (a). CT angiography
revealed the nutrient artery in the lesion (b). Pathology was assessed with hematein-eosin staining and showed that the morphology of tumor cells
was uniform with tubular and acinar architecture (magnification, 40 × 10, c). The arrow marker was used to indicate the cystic changes or necrosis
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gray. The oncocytes were isolated and examined using a
microscope. The results demonstrated that the cell
morphology was uniform, with non-prominent nucleoli
and little eosinophilic cytoplasm. In addition, tumor cells
showed tubular and acinar architecture, leading to the
formation of glomerular-like or bud-like structures.
Intercellular substances showed acellular edema, myx-
oid, and hyaline degeneration. Immunohistochemical
experiments revealed that most tumor cells were positiveFig. 4 A 60-year-old male with metanephric adenoma in the lower pole of th
renal parenchyma (a). T2 weighted, fat suppressed image showed nearly isoin
center (b). The arrow marker was used to indicate the lesionfor vimentin, CK, and EMA, which confirmed the
diagnosis of MA (Fig. 5).
Discussion
MA is the occurrence of an uncommon renal tumor and
was first described as a bilateral and diffuse tumor by
Bove et al. in 1979 [7]. The histologic origin of MA
remains controversial, but most scholars consider it to
be derived from metanephric blastema. In recent years,
emerging MA cases have been reported. MA generallye right kidney (case 8). T1WI of the tumor showed nearly isointense to
tense to renal parenchyma with some slightly hyperintense areas in the
Fig. 5 Immunohistochemical images for vimentin, CK and EMA.
Immunohistochemical experiments revealed that most tumor cells
were positive for vimentin (magnification: 200×, a), CK
(magnification: 200×, b) and EMA (magnification: 200×, c)
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fifth or sixth decade of life, but it is also diagnosed in
children [8, 9]. In the present study, patients’ average
age and the age range at diagnosis was 43.4 years and
17–67 years. It is worth noting that three cases were
under 30 years of age. Unilateral renal onset is more
common, and all our patients were taken bad for
unilateral kidney. However, there are also bilateral
renal cases in a previous report [10]. In addition, MA
seems to be more common in women than in men
[2]. Nevertheless, no gender difference was observed
in this report due to the small sample size.
As was the case with our patients, 50 % were clin-
ically asymptomatic and diagnosed during physical
examination [2]. The symptomatic cases of MA mani-
fested as gross hematuria and flank pain in this study.
Other symptoms, including polycythemia, a palpable
mass, backache, abdominal pain, and fever, have beenfrequently presented in previous reports [11]. It has
been also demonstrated that some patients have
symptoms of urinary tract infections (UTIs). MA has
been reported to have the highest level of polycy-
themia among all kidney tumors [2], which is prob-
ably related to the production of erythropoietin and
multiple cytokines by MA [12]. Asymptomatic cases
go against the discovery of MA. Therefore, physical
examination is important for detection in early stages.
The clinical and imaging features of MA are complex
and varied. It is difficult to give a final conclusion
through preoperative diagnosis, due to the fact that it is
often misdiagnosed as renal cell carcinomas, renal cysts,
and other kidney diseases [3, 13]. In this report, six pa-
tients were preoperatively misdiagnosed as renal cell car-
cinoma and two were preoperatively misdiagnosed as
renal hamartoma. Currently, the final diagnosis has to
rely on pathology [3]. CT is the main imaging method
for the diagnosis of MA. However, no typical radiological
features of MA have been identified [14]. In this study,
plain CT showed that all MA tumors were solid and
87.5 % of the lesions were identified to be isodense and
equal to the normal renal parenchyma. Dynamic
contrast-enhanced CT is the principal characteristic of
MA, and it revealed that enhanced degrees of the tu-
mors in the renal cortex, renal parenchymal, and pelvic
phase were mainly progressive and the levels in all three
phases were lower than that of the normal renal paren-
chyma. MA lacks a blood supply, and the nutrient artery
and neoangiogenesis are rarely observed in lesions.
However, we observed the nutrient artery in one patient.
The features described above help to identify MA and
renal clear cell carcinoma. Renal clear cell carcinoma
is the most common tumor in the kidneys with an
abundant blood supply and the enhancement pattern
of rapid rise-rapid fall, and the enhanced degree of
this tumor is generally higher than that of the normal
renal parenchyma. Calcification is considered a critical
indicator for the diagnosis of MA [15]. Only one of
the eight MA tumors showed calcification in this re-
port. In addition, cystic changes and necrosis were
confirmed in 37.5 % of MA tumors. We found that
MA lesions were located both in the renal cortex and
medulla in 87.5 % of patients. Zhu et al. reported that
seven of eight MA tumors were centered in the renal
medulla [16]. However, a recent study shows that
only 16.7 % of tumors were located entirely within
the renal parenchyma and 83.3 % were located at the
periphery of the renal cortex without involvement of
the renal collecting system [17]. In a previous report,
the renal cortex has been indicated as the predilec-
tion site of MA [2]. The sample size greatly contrib-
utes to the conflicting CT findings for MA. In
addition, we found that the lesions projected outside
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which is one of the principal characters of MA.
The MRI findings of MA are relatively limited. The
typical MRI finding of MA is hypointense (or isointense)
on T1WI and T2WI [4, 11]. In our report, one case of
MA was isointense on T1WI and isointense on T2WI
with some slightly hyperintense areas in the center. Due
to the diversification of MRI findings, more cases need
to be collected and analyzed.
Rare metastatic MA has been reported. In addition,
metastasis of the retroperitoneal enlarged lymph nodes,
renal vessels, and the inferior vena cava was not ob-
served in any case. However, lung metastasis and lymph
node metastasis have been found in a few MA patients
[18, 19]. A follow-up study is important for verifying
metastatic MA.
The histological features of MA are distinctive and are
characterized by epithelial cells with different amounts
of cytoplasm. The adenomatous components are com-
posed of uniform small cells arranged in tubular or pap-
illary architectural patterns [11]. In the present patients,
immunohistochemical staining showed that neoplastic
cells were positive for vimentin, CK, and EMA. Previous
findings demonstrate that CD57, AE1/AE3, and CAM5.2
are also positive in MA, while NSE, CEA, CgA, Syn,
actin, desmin, and AMACR are negative [3, 20]. Patho-
logical detection remains the most effective method for
MA diagnosis.
Conclusions
MA is a rare benign renal neoplasm at any age. It is
easily misdiagnosed in preoperative diagnosis. CT and
MRI findings assist clinicians to better discover and
detect MA. It is even more important to avoid un-
necessary total nephrectomy. However, the final diag-
nosis relies on pathology.
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